Special Issue "Leukemia"
A special issue of Cancers (ISSN 2072-6694).
Deadline for manuscript submissions: closed (31 July 2012)
Dr. Charles H. Lawrie
Lymphoid Malignancy Research Group, Nuffield Department of Clinical Laboratory Sciences, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DU, UK
Phone: +44 1865 220344
Interests: cancer; lymphoma; leukemia; microarray; microRNA; biomarkers; non-coding RNA
Leukemia (leukaemia- British spelling) is a malignancy of the blood originating from immature leukocytes (lymphoid and myeloid). It is the most common form of childhood cancer (~1/3 of cases) and accounts for >44,000 new diagnoses and >22,000 mortalities annually in the US alone. Recent advances in both laboratory and clinic continue to improve the outcome for patients. This special edition of Cancers gives an opportunity to describe recent original research in the field of leukemia, the development or application of new platforms or insights, and/or reviews of the field. We are particularly interested in genomics, leukemia stem cell research, novel therapeutics, epidemiological studies and new biomarker studies. If you would like to discuss an idea for a paper before committing please contact the guest editor.
Dr. Charles Lawrie
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. Papers will be published continuously (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are refereed through a peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed Open Access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 500 CHF (Swiss Francs). English correction and/or formatting fees of 250 CHF (Swiss Francs) will be charged in certain cases for those articles accepted for publication that require extensive additional formatting and/or English corrections.
- acute lymphoblastic leukemia (ALL)
- chronic lymphocytic leukemia (CLL)
- acute myelogenous leukemia (AML)
- chronic myelogenous leukemia (CML)
- hairy cell leukemia (HCL)
- T-cell prolymphocytic leukemia (T-PLL)
- large granular lymphocytic leukemia
- adult T-cell leukemia
- human T-lymphotropic virus (HTLV)
Article: Minimal Residual Disease as a Predictive Factor for Relapse after Allogeneic Hematopoietic Stem Cell Transplant in Adult Patients with Acute Myeloid Leukemia in First and Second Complete Remission
Cancers 2012, 4(2), 601-617; doi:10.3390/cancers4020601
Received: 17 May 2012; in revised form: 13 June 2012 / Accepted: 14 June 2012 / Published: 20 June 2012| Download PDF Full-text (242 KB) | Download XML Full-text
Article: Membrane Type-1 Matrix Metalloproteinase Expression in Acute Myeloid Leukemia and Its Upregulation by Tumor Necrosis Factor-α
Cancers 2012, 4(3), 743-762; doi:10.3390/cancers4030743
Received: 1 June 2012; in revised form: 11 July 2012 / Accepted: 13 July 2012 / Published: 25 July 2012| Download PDF Full-text (359 KB) | Download XML Full-text
Cancers 2012, 4(3), 904-944; doi:10.3390/cancers4030904
Received: 2 August 2012; in revised form: 31 August 2012 / Accepted: 4 September 2012 / Published: 10 September 2012| Download PDF Full-text (421 KB) | Download XML Full-text
Cancers 2012, 4(4), 1036-1049; doi:10.3390/cancers4041036
Received: 26 July 2012; in revised form: 14 September 2012 / Accepted: 9 October 2012 / Published: 18 October 2012| Download PDF Full-text (733 KB) | Download XML Full-text
Article: Mouse Lymphoblastic Leukemias Induced by Aberrant Prdm14 Expression Demonstrate Widespread Copy Number Alterations Also Found in Human ALL
Cancers 2012, 4(4), 1050-1066; doi:10.3390/cancers4041050
Received: 26 July 2012; in revised form: 2 October 2012 / Accepted: 9 October 2012 / Published: 18 October 2012| Download PDF Full-text (968 KB) | Download XML Full-text |
Cancers 2012, 4(4), 1161-1179; doi:10.3390/cancers4041161
Received: 22 August 2012; in revised form: 29 September 2012 / Accepted: 17 October 2012 / Published: 2 November 2012| Download PDF Full-text (422 KB) | Download XML Full-text
Article: A Novel Three-Colour Fluorescence in Situ Hybridization Approach for the Detection of t(7;12)(q36;p13) in Acute Myeloid Leukaemia Reveals New Cryptic Three Way Translocation t(7;12;16)
Cancers 2013, 5(1), 281-295; doi:10.3390/cancers5010281
Received: 31 January 2013; in revised form: 28 February 2013 / Accepted: 4 March 2013 / Published: 11 March 2013| Download PDF Full-text (884 KB) | Download XML Full-text
Last update: 26 September 2012